Parion Sciences Announces Upcoming Presentations of Data at the North American Cystic Fibrosis Conference Being Held October 8 through 10, 2015

  • Data from preclinical and clinical research on P-1037(VX-371) to be presented
  • Additional data presentation includes a review of a novel in silico approach towards identification of CFTR correctors

Durham, NC (October 5, 2015) – Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced that 3 abstracts from its pulmonary research and development efforts will be presented at the 29th Annual North American Cystic Fibrosis Conference (NACFC) in Phoenix Arizona, October 8 through 10, 2015. Data to be presented on P-1037 (also known as VX-371) includes preclinical models as well as a review of the clinical data. A review of a novel in silico model to identify new CFTR correctors

READ THE ENTIRE PRESS RELEASE HERE ►